{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:46:09Z","timestamp":1773297969813,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"MEXT","doi-asserted-by":"crossref","award":["S1411019"],"award-info":[{"award-number":["S1411019"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ejps.2016.03.019","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T07:05:40Z","timestamp":1461222340000},"page":"298-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Mice with neuropathic pain exhibit morphine tolerance due to a decrease in the morphine concentration in the brain"],"prefix":"10.1016","volume":"92","author":[{"given":"Wataru","family":"Ochiai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsumasa","family":"Kaneta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Nagae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami","family":"yuzuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Hanagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kitaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Suto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risako","family":"Kon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Masukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutomo","family":"Ikarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5558-9906","authenticated-orcid":false,"given":"Kiyoshi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2016.03.019_bb0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-3565(25)20113-6","article-title":"Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood\u2013brain barrier in the rat","volume":"278","author":"Bickel","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2016.03.019_bb0010","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1046\/j.1471-4159.2003.01990.x","article-title":"Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood\u2013brain barrier","volume":"86","author":"Bourasset","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2016.03.019_bb0015","first-page":"1","article-title":"Human UGT2B7 catalyzes morphine glucuronidation","volume":"25","author":"Coffman","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2016.03.019_bb0020","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/j.1582-4934.2009.00932.x","article-title":"BiP, an endoplasmic reticulum chaperone, modulates the development of morphine antinociceptive tolerance","volume":"14","author":"Dobashi","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ejps.2016.03.019_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neulet.2010.08.084","article-title":"Valproate attenuates the development of morphine antinociceptive tolerance","volume":"485","author":"Dobashi","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejps.2016.03.019_bb0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/eujp.2001.0250","article-title":"von Frey hairs: new materials for a new design","volume":"5","author":"Fruhstorfer","year":"2001","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejps.2016.03.019_bb0035","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pbb.2006.10.018","article-title":"P-glycoprotein ATPase activating effect of opioid analgesics and their P-glycoprotein-dependent antinociception in mice","volume":"85","author":"Hamabe","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejps.2016.03.019_bb0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1254\/jphs.FP0071287","article-title":"Negative relationship between morphine analgesia and P-glycoprotein expression levels in the brain","volume":"105","author":"Hamabe","year":"2007","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2016.03.019_bb0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1211\/jpp.62.03.0004","article-title":"The pharmacokinetics of morphine and its glucuronide conjugate in a rat model of streptozotocin-induced diabetes and the expression of MRP2, MRP3 and UGT2B1 in the liver","volume":"62","author":"Hasegawa","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2016.03.019_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0031-9384(95)00046-L","article-title":"Tail-flick test. I: impact of a suprathreshold exposure to radiant heat on pain reactivity in rats","volume":"58","author":"Kallina","year":"1995","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejps.2016.03.019_bb0055","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1017\/S0265021507000221","article-title":"Assessment of the clinical relevance of quantitative sensory testing with von Frey monofilaments in patients with allodynia and neuropathic pain. A pilot study","volume":"24","author":"Keizer","year":"2007","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.ejps.2016.03.019_bb0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/AJP.0b013e3181673b80","article-title":"Quantitative sensory testing with von Frey monofilaments in patients with allodynia: what are we quantifying?","volume":"24","author":"Keizer","year":"2008","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.ejps.2016.03.019_bb0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.clpt.2003.08.011","article-title":"Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine","volume":"74","author":"Kharasch","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2016.03.019_bb0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1248\/bpb1978.14.187","article-title":"Species difference of site-selective glucuronidation of morphine","volume":"14","author":"Kuo","year":"1991","journal-title":"J. Pharmacobiodyn."},{"key":"10.1016\/j.ejps.2016.03.019_bb0075","first-page":"2042","article-title":"Considerations in morphine therapy","volume":"51","author":"Laizure","year":"1994","journal-title":"Am. J. Hosp. Pharm."},{"key":"10.1016\/j.ejps.2016.03.019_bb0080","first-page":"351","article-title":"No contribution of morphine-6-glucuronide to clinical morphine effects after short-term administration","volume":"21","author":"Lotsch","year":"1998","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejps.2016.03.019_bb0085","first-page":"54","article-title":"Rodent analgesiometry: the hot plate, tail flick and von Frey hairs","volume":"43","author":"Mulder","year":"2004","journal-title":"Contemp. Top. Lab. Anim. Sci."},{"key":"10.1016\/j.ejps.2016.03.019_bb0090","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.npp.1301471","article-title":"Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine","volume":"33","author":"Narita","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejps.2016.03.019_bb0095","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/dmd.107.019281","article-title":"Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties","volume":"36","author":"Ohno","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2016.03.019_bb0100","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1211\/jpp.61.05.0007","article-title":"Effects of quinidine on antinociception and pharmacokinetics of morphine in rats","volume":"61","author":"Okura","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2016.03.019_bb0105","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0140-6736(88)91691-1","article-title":"Analgesic activity of morphine-6-glucuronide","volume":"1","author":"Osborne","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2016.03.019_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-0270(99)00004-7","article-title":"Paw withdrawal threshold in the von Frey hair test is influenced by the surface on which the rat stands","volume":"87","author":"Pitcher","year":"1999","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejps.2016.03.019_bb0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1570-0232(02)00726-2","article-title":"Rapid and simple method to determine morphine and its metabolites in rat plasma by liquid chromatography\u2013mass spectrometry","volume":"787","author":"Projean","year":"2003","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2016.03.019_bb0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jchromb.2005.05.048","article-title":"The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry","volume":"824","author":"Rook","year":"2005","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2016.03.019_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","article-title":"A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury","volume":"43","author":"Seltzer","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2016.03.019_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejphar.2003.11.028","article-title":"Decrease in serotonin concentration in raphe magnus nucleus and attenuation of morphine analgesia in two mice models of neuropathic pain","volume":"484","author":"Sounvoravong","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2016.03.019_bb0135","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1248\/bpb.28.2026","article-title":"Modulation of UDP-glucuronosyltransferase 2B7 function by cytochrome P450s in vitro: differential effects of CYP1A2, CYP2C9 and CYP3A4","volume":"28","author":"Takeda","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2016.03.019_bb0140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nm.2633","article-title":"Blockade of PDGFR-beta activation eliminates morphine analgesic tolerance","volume":"18","author":"Wang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2016.03.019_bb0145","first-page":"768","article-title":"Blood\u2013brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine","volume":"25","author":"Wu","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2016.03.019_bb0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0304-3959(82)90096-3","article-title":"Substance P reduces tail-flick latency: implications for chronic pain syndromes","volume":"14","author":"Yasphal","year":"1982","journal-title":"Pain"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716300926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716300926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T20:52:20Z","timestamp":1748897540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098716300926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":30,"alternative-id":["S0928098716300926"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2016.03.019","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mice with neuropathic pain exhibit morphine tolerance due to a decrease in the morphine concentration in the brain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2016.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}